Cargando…

Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis

Objective: A network meta-analysis based on randomized controlled trials was conducted to investigate the effects of pharmacological interventions on smoking cessation. Methods: English databases were searched to obtain randomized controlled trials reporting the effect of pharmacological interventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Xue, Guo, Kangle, E., Fenfen, Deng, Xinxin, Wang, Yongsheng, Wang, Ziyi, Wu, Yanan, Xu, Meng, Yang, Chaoqun, Li, Xiuxia, Yang, Kehu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638092/
https://www.ncbi.nlm.nih.gov/pubmed/36353488
http://dx.doi.org/10.3389/fphar.2022.1012433
_version_ 1784825331310395392
author Shang, Xue
Guo, Kangle
E., Fenfen
Deng, Xinxin
Wang, Yongsheng
Wang, Ziyi
Wu, Yanan
Xu, Meng
Yang, Chaoqun
Li, Xiuxia
Yang, Kehu
author_facet Shang, Xue
Guo, Kangle
E., Fenfen
Deng, Xinxin
Wang, Yongsheng
Wang, Ziyi
Wu, Yanan
Xu, Meng
Yang, Chaoqun
Li, Xiuxia
Yang, Kehu
author_sort Shang, Xue
collection PubMed
description Objective: A network meta-analysis based on randomized controlled trials was conducted to investigate the effects of pharmacological interventions on smoking cessation. Methods: English databases were searched to obtain randomized controlled trials reporting the effect of pharmacological interventions on smoking cessation. The risk of bias for the included trials was assessed using Cochrane Handbook tool. Stata 15.1 software was used to perform network meta-analysis, and GRADE approach was used to assess the evidence credibility on the effects of different interventions on smoking cessation. Results: A total of 159 studies involving 60,285 smokers were included in the network meta-analysis. The analysis involved 15 interventions and which yielded 105 pairs of comparisons. Network meta-analysis showed that varenicline was more helpful for smoking cessation than other monotherapies, such as nicotine replacement therapy [Odds Ratio (OR) = 1.42, 95% confidence interval (CI) (1.16, 1.73)] and bupropion [OR = 1.52, 95% CI (1.22, 1.89)]. Furthermore, combined interventions were superior to monotherapy in achieving smoking cessation, such as varenicline plus bupropion over bupropion [OR = 2.00, 95% CI (1.11, 3.61)], varenicline plus nicotine replacement therapy over nicotine replacement therapy [OR = 1.84, 95% CI (1.07, 3.18)], and nicotine replacement therapy plus mecamylamine over naltrexone [OR = 6.29, 95% CI (1.59, 24.90)]. Finally, the surface under the cumulative ranking curve value indicated that nicotine replacement therapy plus mecamylamine had the greatest probability of becoming the best intervention. Conclusion: Most pharmacological interventions demonstrated a benefit in smoking cessation compared with placebo, whether monotherapy or combination therapy. Moreover, confirmed evidence suggested that some combination treatments, such as varenicline plus bupropion and nicotine replacement therapy plus mecamylamine have a higher probability of being the best smoking cessation in
format Online
Article
Text
id pubmed-9638092
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96380922022-11-08 Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis Shang, Xue Guo, Kangle E., Fenfen Deng, Xinxin Wang, Yongsheng Wang, Ziyi Wu, Yanan Xu, Meng Yang, Chaoqun Li, Xiuxia Yang, Kehu Front Pharmacol Pharmacology Objective: A network meta-analysis based on randomized controlled trials was conducted to investigate the effects of pharmacological interventions on smoking cessation. Methods: English databases were searched to obtain randomized controlled trials reporting the effect of pharmacological interventions on smoking cessation. The risk of bias for the included trials was assessed using Cochrane Handbook tool. Stata 15.1 software was used to perform network meta-analysis, and GRADE approach was used to assess the evidence credibility on the effects of different interventions on smoking cessation. Results: A total of 159 studies involving 60,285 smokers were included in the network meta-analysis. The analysis involved 15 interventions and which yielded 105 pairs of comparisons. Network meta-analysis showed that varenicline was more helpful for smoking cessation than other monotherapies, such as nicotine replacement therapy [Odds Ratio (OR) = 1.42, 95% confidence interval (CI) (1.16, 1.73)] and bupropion [OR = 1.52, 95% CI (1.22, 1.89)]. Furthermore, combined interventions were superior to monotherapy in achieving smoking cessation, such as varenicline plus bupropion over bupropion [OR = 2.00, 95% CI (1.11, 3.61)], varenicline plus nicotine replacement therapy over nicotine replacement therapy [OR = 1.84, 95% CI (1.07, 3.18)], and nicotine replacement therapy plus mecamylamine over naltrexone [OR = 6.29, 95% CI (1.59, 24.90)]. Finally, the surface under the cumulative ranking curve value indicated that nicotine replacement therapy plus mecamylamine had the greatest probability of becoming the best intervention. Conclusion: Most pharmacological interventions demonstrated a benefit in smoking cessation compared with placebo, whether monotherapy or combination therapy. Moreover, confirmed evidence suggested that some combination treatments, such as varenicline plus bupropion and nicotine replacement therapy plus mecamylamine have a higher probability of being the best smoking cessation in Frontiers Media S.A. 2022-10-24 /pmc/articles/PMC9638092/ /pubmed/36353488 http://dx.doi.org/10.3389/fphar.2022.1012433 Text en Copyright © 2022 Shang, Guo, E., Deng, Wang, Wang, Wu, Xu, Yang, Li and Yang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Shang, Xue
Guo, Kangle
E., Fenfen
Deng, Xinxin
Wang, Yongsheng
Wang, Ziyi
Wu, Yanan
Xu, Meng
Yang, Chaoqun
Li, Xiuxia
Yang, Kehu
Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
title Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
title_full Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
title_fullStr Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
title_full_unstemmed Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
title_short Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
title_sort pharmacological interventions on smoking cessation: a systematic review and network meta-analysis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638092/
https://www.ncbi.nlm.nih.gov/pubmed/36353488
http://dx.doi.org/10.3389/fphar.2022.1012433
work_keys_str_mv AT shangxue pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT guokangle pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT efenfen pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT dengxinxin pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT wangyongsheng pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT wangziyi pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT wuyanan pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT xumeng pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT yangchaoqun pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT lixiuxia pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis
AT yangkehu pharmacologicalinterventionsonsmokingcessationasystematicreviewandnetworkmetaanalysis